Focusing on oncogenic driver mutations and resistance mechanisms in the treatment of NSCLC : vimarsana.com

Lung cancer is the leading cause of cancer-related death worldwide. Improved understanding of driver mutations of non-small cell lung cancer (NSCLC) has led to more biomarker-directed treatment for patients with advanced stages.

Related Keywords

, Higher Education , Cancer , Ell , Ung Cancer , On Small Cell Lung Cancer , Mall Cell Lung Cancer , Iomarker , Rugs , Xon , Ene , Rowth Factor , Istology , Hc , Mmunohistochemistry , Mmunotherapy , Inase , Igand , Ymphoma , Utation , Ncogene , D L1 , Eceptor , Esearch , Ransfection , Yrosine ,